Psoriatic Arthritis Clinical Trials, Emerging Therapies, Key Companies | A Drug Pipeline Analysis Report 2023 | DelveInsight

February 07 02:10 2023
Psoriatic Arthritis Clinical Trials, Emerging Therapies, Key Companies | A Drug Pipeline Analysis Report 2023 | DelveInsight
DelveInsight’s, “Psoriatic Arthritis– Pipeline Insight, 2023,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Psoriatic Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

DelveInsight’s Psoriatic Arthritis Pipeline Insight 2023 report provides comprehensive global coverage of available, marketed, and pipeline Psoriatic Arthritis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Psoriatic Arthritis pipeline domain.


Key Takeaways from the Psoriatic Arthritis Pipeline Report

  • Over 50+ Psoriatic Arthritis pipeline therapies are in various stages of development, and their anticipated acceptance in the Psoriatic Arthritis market would significantly increase market revenue. 
  • Leading Psoriatic Arthritis companies developing novel drug candidates to improve the Psoriatic Arthritis treatment landscape include AbbVie, and others.
  • Promising Psoriatic Arthritis pipeline therapies in various stages of development include ABT-494, Risankizumab, and others.


Psoriatic Arthritis Overview

Psoriatic Arthritis is a chronic inflammatory disease of the joints that can be associated with the psoriasis. It can affect both peripheral joints and axial skeleton causing pain, stiffness, swelling and joint destruction. This joint pathology develops gradually and cause more nuisance than disabling. 

Psoriatic arthritis is considered as seronegative spondyloarthropathies. The fact that it is Seronegative is that the blood tests negative for some factors that is present in rheumatoid arthritis. 

Spondyloarthropathy describes a group of conditions that all share common characteristics. First, there is a presence of arthritis that affects the spine. Second, inflammation occurs in ligaments, tendons and sometimes in other organs such as the eye.


Request for a sample report to know more about rheumatoid arthritis treatment algorithm and diagnosis.


Psoriatic Arthritis Pipeline Analysis: Drug Profile

Risankizumab: Abbvie

Risankizumab is an interleukin-23 (IL-23) inhibitor that selectively blocks IL-23 by binding to its p19 subunit. IL-23, a cytokine involved in inflammatory processes, is thought to be linked to a number of chronic immune-mediated diseases, including psoriasis.


Discover more about the emerging Psoriatic Arthritis drugs @ Psoriatic Arthritis Treatment Drugs


Psoriatic Arthritis Key Companies

  • AbbVie


Psoriatic Arthritis Pipeline Therapies

  • ABT-494
  • Risankizumab


Psoriatic Arthritis Pipeline Therapeutics Assessment

  • By development stage
  • By product type
  • By route of administration
  • By molecule type
  • By MOA type 


Scope of the Psoriatic Arthritis Pipeline Report 

  • Coverage: Global 
  • Key Psoriatic Arthritis Companies: AbbVie, and others
  • Key Psoriatic Arthritis Pipeline Therapies: ABT-494, Risankizumab, and others


Find out more about the Psoriatic Arthritis treatment options in development @ Psoriatic Arthritis Clinical Trials


Table of Contents

1. Introduction

2. Executive Summary

3. Overview

4. Pipeline Therapeutics

5. Late-Stage Products (Phase III)

6. Mid-Stage Products (Phase  II)

7. Early Stage Products (Phase  I/II)

8. Preclinical Stage Products

9. Discovery Stage Products

10. Therapeutic Assessment

11. Inactive Products

12. Collaborations Assessment- Licensing / Partnering / Funding

13. Unmet Needs

14. Market Drivers and Barriers

15. Appendix

16. About DelveInsight


Other Trending Reports:

  • Asthma Diagnostic Devices Market
  • Chronic Obstructive Pulmonary Disease Treatment Devices Market
  • Airway Management Devices Market
  • Cough Assist Devices Market
  • Pulse Oximeters Market
  • Hemodialysis Catheter Devices Market
  • Chronic Spontaneous Urticaria Market 
  • Gender Dysphoria Market
  • Germany Healthcare Outlook
  • Biopsy Devices Pipeline Insight
  • Bacterial Conjunctivitis Market
  • Infliximab Biosimilar Insight
  • Eosinophilic Asthma Market
  • Cushing Syndrome Market


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. 


Contact Us

Kritika Rehani

[email protected] 


Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States